A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer-Reference-Cited by-同舟云学术

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

Published:2011-12 Issue:3 Volume:123 Page:486-491
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Adams Sarah F.,Marsh Evelyn B.,Elmasri Wafic,Halberstadt Steffanie,VanDecker Stephanie,Sammel Mary D.,Bradbury Angela R.,Daly Mary,Karlan Beth,Rubin Stephen C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference26 articles.

1. BRCA-related ovarian carcinoma;Rubin;Cancer,2003

2. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers;Rebbeck;J Natl Cancer Inst,2009

3. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer;Risch;Am J Hum Genet,2001

4. Prophylactic oophorectomy in women at increased cancer risk;Domchek;Curr Opin Obstet Gynecol,2007

5. Improved survival in women with BRCA-associated ovarian carcinoma;Cass;Cancer,2003

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles;Environmental Research;2024-03

2. Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer;Gynecologic Oncology;2022-11

3. Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study;Clinical Cancer Research;2022-10-13

4. A clinical case of repeat use of PARP inhibitors in a patient with <i>mBRCA</i>-associated ovarian cancer;Siberian journal of oncology;2022-09-02

5. Association of BRCA1 /2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta‐analysis;Journal of Obstetrics and Gynaecology Research;2022-06-13